Medicine for treating systemic lupus erythematosus

A systemic technology for lupus erythematosus, applied in the field of drugs, can solve problems such as side effects, poor curative effect, and drugs that cannot meet the needs of patients, and achieve quick results.

Inactive Publication Date: 2019-03-05
吴颖
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are also many drugs for the treatment of systemic lupus erythematosus, but most of them are not very effective, an

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0010] The present invention will be further described in detail in conjunction with specific embodiments below.

[0011] A drug for treating systemic lupus erythematosus, consisting of:

[0012] 10g-20g of black medicine, 10g-20g of cinnamon, 10g-20g of ginger, 10g-20g of Codonopsis, 10g-20g of cicadae, 10g-20g of sesame oil, 10g-20g of Huoxiang, 10g-20g of Dirong, 10g of celandine 20g and an arrow 10g-20g.

[0013] As a preference, the medicine can be made into decoction.

[0014] Preferably, the drug can be made into tablets.

[0015] Preferably, the drug can be made into capsules.

[0016] The beneficial effect of the invention is that it can effectively treat systemic lupus erythematosus, has quick effect, has no side effect and is suitable for people of all ages and genders.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine for treating systemic lupus erythematosus. The medicine comprises 10-20 g of radix linderae, 10-20 g of cortex cinnamomi, 10-20 g of rhizoma alpiniae officinarum, 10-20 g of radix codonopsis, 10-20 g of cordyceps sobolifera, 10-20 g of oleum sesami, 10-20 g of agastache rugosa, 10-20 g of stephania epigeae, 10-20 g of chelidonium majus and 10-20 g of ophioglossumpedunculosum. The medicine has the advantages that the systemic lupus erythematosus can be effectively treated by the medicine, and the medicine can become effective fast and is free of side effect and applicable to people who are of different genders at different age groups.

Description

technical field [0001] The invention belongs to the field of medicines, in particular to a medicine for treating systemic lupus erythematosus. Background technique [0002] Systemic lupus erythematosus is a common, multiple disease that can occur in all age groups, men, women, and children. At present, there are also many drugs for treating systemic lupus erythematosus, but most of them are not very effective, and many drugs will produce certain side effects. With the development of society, these drugs can no longer meet the needs of patients. Contents of the invention [0003] The technical problem to be solved by the present invention is to provide a drug for treating systemic lupus erythematosus, which can treat systemic lupus erythematosus conveniently and has no side effects. [0004] The technical solution adopted in the present invention is: a medicine for treating systemic lupus erythematosus, which consists of the following components: [0005] 10g-20g of blac...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/9062A61P37/02A61P19/04
CPCA61K36/54A61K36/068A61K36/12A61K36/185A61K36/344A61K36/532A61K36/59A61K36/66A61K36/9062A61K2300/00
Inventor 吴颖
Owner 吴颖
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products